MindLeap Health Enters into Fast-Growing Telehealth Market
September 29th, 2020
App, Exclusive, Psychedelics, Top Story
The COVID-19 pandemic has led to dramatic changes in healthcare. In addition to mobilizing a vaccine in record time, the pandemic could permanently alter the way that many people seek medical care, shifting from in-person to telehealth. These changes have created an enormous opportunity for companies to innovate in the remote delivery of health services.
Telehealth Poised for Growth
The telehealth market is projected to become a nearly $560 billion market by 2027, according to Fortune Business Insights™, which represents a blistering 25.2% compound annual growth rate. While the COVID-19 pandemic has accelerated demand for e-visits, telehealth also offers easier access to required doctors, lower patient waiting times and greater cost efficiency.
Growth in the Global Telehealth Market – Source: Grand View Research
These growth rates have led to strong growth among the handful of public companies focused on telehealth. There has also been growing M&A interest in the space following Teladoc Health’s move to acquire InTouch Health and Zava’s $32 million Series A that was funded by HPE Growth, representing a significant investment in the space.
Performance of Telehealth Public Companies – Source: Yahoo! Finance
MindLeap Launches Platform
MindLeap Health recently launched a telehealth platform that will be officially available on Apple iOS and Google Android stores on September 30, 2020. The platform enables users to browse vetted and experienced specialists, easily schedule appointments and purchase mental health services through an intuitive and easy to use application.
Mental health specialists using the MindLeap platform can easily manage their virtual practice on their own terms by setting their own prices and choosing the hours that they work each week. MindLeap takes a 9% cut of each session’s fee in exchange for providing access to its built-in user base and technology.
Click the image to see an introduction to the MindLeap app and gain early access
Unlike other mental health platforms, MindLeap is uniquely designed to offer psychedelic integration services with over 30 professionals able to offer mental health support. These specialists can help clients through a systematic process that turns psychedelic experiences into something practical—although they don’t remotely guide the actual experiences.
Mydecine Innovation Group (CSE: MYCO) (OTC: MYCOF) (FFT: 0NF) is uniquely positioned to benefit from the growth in the telehealth market, and in particular, growing demand for mental health services. As the psychedelic market matures, the company’s platform has an opportunity to experience significant growth as other telemedicine companies in this enormous and fast growing market.
In addition to MindLeap, Mydecine Innovation Group is conducting the world’s first clinical trial of psilocybin for the treatment of post-traumatic stress disorder, or PTSD, a market worth $7.8 billion. The company is entering into Phase I clinical trials this month and has various other psychedelic drug candidates in development at their laboratories in Denver and Alberta.
Investors may want to take a closer look at the stock given its unique exposure to two rapidly growing markets—telehealth and psychedelics.
Sign up here to get access to the Mindleap app.
The above article is sponsored content. CannabisFN.com and CFN Media, have been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.